-+ 0.00%
-+ 0.00%
-+ 0.00%

ACURX ANNOUNCES NEW IBEZAPOLSTAT CLINICAL TRIAL PROGRAM IN PATIENTS WITH RECURRENT CDI THAT HAS THE POTENTIAL TO SHIFT THE PARADIGM OF TREATMENT AND PREVENTION OF C. DIFFICILE INFECTION

Reuters·03/09/2026 12:01:00

Please log in to view news